20.78

0.72% -0.15

After Hours: 20.78

Sabra Healthcare Reit Inc (SBRA)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Sabra Healthcare Reit Inc stock is traded at $20.78, with a volume of 1.95M. It is down -0.72% in the last 24 hours and up +0.58% over the past month. Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.

Previous Close:

$20.93

Open:

$20.78

24h Volume:

1.95M

Relative Volume:

0.66

Market Cap:

$5.31B

Revenue:

$810.81M

Net Income/Loss:

$156.02M

P/E Ratio:

32.88

EPS:

0.6319

Net Cash Flow:

$373.47M

1W Performance:

+0.82%

1M Performance:

+0.58%

6M Performance:

+2.62%

1Y Performance:

+8.91%

1-Day Range:

$20.75

$21.18

1-Week Range:

$20.25

$21.18

52-Week Range:

$17.16

$22.77

Sabra Healthcare Reit Inc Stock (SBRA) Company Profile

Name

Sabra Healthcare Reit Inc

Sector

Real Estate (254)

Industry

REIT - Healthcare Facilities (17)

Phone

888-393-8248

Address

1781 FLIGHT WAY, TUSTIN, CA

Employee

Twitter

Next Earnings Date

2026-08-03

Latest SEC Filings

SBRA's Discussions on Twitter

Compare SBRA vs WELL, VTR, DOC, OHI, AHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SBRA Sabra Healthcare Reit Inc	20.78	5.24B	810.81M	156.02M	373.47M	0.6319
WELL Welltower Inc	236.17	171.06B	11.75B	1.46B	2.19B	-0.6014
VTR Ventas Inc	90.27	47.54B	6.13B	272.21M	1.38B	0.5521
DOC Healthpeak Properties Inc	20.65	14.62B	2.87B	250.10M	1.13B	0.3188
OHI Omega Healthcare Investors Inc	46.38	14.17B	1.24B	655.98M	857.80M	2.063
AHR American Healthcare Reit Inc	54.72	12.16B	2.37B	101.67M	169.19M	0.5775

Sabra Healthcare Reit Inc Stock (SBRA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-18-25	Initiated	UBS	Neutral
Oct-01-25	Initiated	Cantor Fitzgerald	Neutral
Jan-17-25	Downgrade	Truist	Buy → Hold
Jan-07-25	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Dec-05-24	Downgrade	Mizuho	Outperform → Neutral
Oct-01-24	Upgrade	Wells Fargo	Equal Weight → Overweight
Sep-13-24	Upgrade	Citigroup	Neutral → Buy
Jan-30-24	Initiated	Deutsche Bank	Buy
Oct-17-23	Downgrade	BMO Capital Markets	Outperform → Market Perform
Oct-16-23	Upgrade	Wells Fargo	Underweight → Equal Weight
Oct-10-23	Upgrade	BofA Securities	Neutral → Buy
Oct-03-23	Initiated	Wedbush	Outperform
Sep-20-23	Upgrade	Jefferies	Hold → Buy
Aug-11-23	Upgrade	BofA Securities	Underperform → Neutral
Jul-27-23	Initiated	Berenberg	Hold
Apr-20-23	Initiated	Wells Fargo	Underweight
Dec-13-22	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Nov-14-22	Downgrade	BofA Securities	Neutral → Underperform
Oct-10-22	Downgrade	Robert W. Baird	Outperform → Neutral
Jun-30-22	Downgrade	Jefferies	Buy → Hold
Jun-03-22	Initiated	CapitalOne	Equal Weight
May-25-22	Upgrade	Mizuho	Neutral → Buy
Apr-18-22	Downgrade	Barclays	Overweight → Equal Weight
Mar-11-22	Upgrade	BofA Securities	Underperform → Neutral
Feb-18-22	Initiated	KeyBanc Capital Markets	Sector Weight
Feb-01-22	Initiated	Credit Suisse	Neutral
Oct-08-21	Initiated	Robert W. Baird	Outperform
Sep-30-21	Upgrade	Truist	Hold → Buy
Jul-14-21	Resumed	Mizuho	Neutral
May-21-21	Upgrade	BMO Capital Markets	Market Perform → Outperform
May-10-21	Upgrade	Stifel	Hold → Buy
Jan-13-21	Upgrade	Jefferies	Hold → Buy
Jan-13-21	Downgrade	Mizuho	Buy → Neutral
Jan-08-21	Upgrade	BMO Capital Markets	Underperform → Market Perform
Dec-03-20	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Sep-02-20	Resumed	Stifel	Hold
Jun-23-20	Upgrade	Scotiabank	Sector Underperform → Sector Perform
Jun-08-20	Resumed	JMP Securities	Mkt Perform
May-18-20	Upgrade	Berenberg	Hold → Buy
Mar-23-20	Downgrade	BofA/Merrill	Neutral → Underperform
Feb-26-20	Upgrade	Mizuho	Neutral → Buy
Feb-05-20	Initiated	Berenberg	Hold
Dec-20-19	Initiated	Mizuho	Neutral
Dec-18-19	Upgrade	Citigroup	Sell → Neutral
Oct-14-19	Resumed	BofA/Merrill	Neutral
Sep-23-19	Downgrade	Citigroup	Neutral → Sell
Sep-03-19	Initiated	Barclays	Overweight
Dec-18-18	Downgrade	SunTrust	Buy → Hold
Nov-16-18	Downgrade	BofA/Merrill	Neutral → Underperform
May-21-18	Upgrade	Raymond James	Mkt Perform → Outperform
Mar-26-18	Upgrade	BofA/Merrill	Underperform → Neutral
Feb-22-18	Reiterated	Stifel	Hold
Dec-21-17	Downgrade	Jefferies	Buy → Hold
Sep-25-17	Initiated	CapitalOne	Equal Weight

View All

Sabra Healthcare Reit Inc Stock (SBRA) Latest News

Sep 02, 2026

Sabra Health Care REIT (SBRA) director now holds 117,137 stock units - Stock Titan

Sep 02, 2026

Sabra Health Care REIT (SBRA) director granted dividend stock units - Stock Titan

Sep 02, 2026

Director at Sabra (NASDAQ: SBRA) now holds 86,912 stock units after latest grant - Stock Titan

Sep 02, 2026

Sabra (NASDAQ: SBRA) director now holds 82,834 stock units - Stock Titan

Sep 02, 2026

Sabra Health Care REIT (SBRA) director gains 791 stock units via dividend credit - Stock Titan

Sep 02, 2026

Dividend credits add 791 units to Sabra (SBRA) director’s stake - Stock Titan

Sep 02, 2026

Sabra Health Care REIT (SBRA) CEO holds 956,268 units and 1,857,686 shares - Stock Titan

Sep 02, 2026

Sep 01, 2026

Headlands Technologies LLC Has $1.32 Million Position in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat

Sep 01, 2026

Aug 31, 2026

Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price Expected to Rise, Robert W. Baird Analyst Says - MarketBeat

Aug 31, 2026

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Aug 31, 2026

Aug 16, 2026

SBRA Q2 2026 Earnings: Steep EPS Miss of 156.72% Met With 2.37% Share GainEarnings Preview - vinanet.vn

Aug 16, 2026

Sabra Healthcare REIT Earnings Call Signals Steady Growth - The Globe and Mail

Aug 16, 2026

Aug 14, 2026

Sabra Health Care REIT (SBRA) Advances 2.37% to $20.32, Pressing Toward Resistance at $21.34Synthetic Long - vinanet.vn

Aug 14, 2026

Aug 13, 2026